Desk›Healthcare› SMS Pharmaceuticals Ltd
SMS Pharmaceuticals Ltd
BSE 532815 · NSE SMSPHARMA · ISIN INE812G01025 · Group B · Active
Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals
₹362.75
+1.37%
BSE close, 28 August 2026
₹3,397.23 cr
9.4 cr shares · Micro cap
₹1,061.35 cr
as published
37.5× · 5.68×
EPS ₹9.67 · BV ₹63.86
886.87 / 87.61
₹ cr, as filed
23
4 selected · 17%
Reg 30
Sch. III Part A
Price 52-week, BSE
| Against 52-week high | -18.8% |
|---|---|
| Against 52-week low | +64.3% |
| Day change | +1.37% |
| Size band | Micro cap |
| Index membership | None |
Valuation as published by BSE
| Earnings per share | ₹9.67 |
|---|---|
| Price / earnings | 37.51× |
| Price / book | 5.68× |
| Book value — derived, price ÷ P/B | ₹63.86 |
| Return on equity | 15.15% |
| Operating margin | 21.08% |
| Net margin | 10.21% |
Consistency check
- P/B ÷ P/E, which must equal ROE
- 15.14%
- ROE as published
- 15.15%
Results ₹ crore, as filed
RevenueNet profit one scale across all three periods, ₹ crore
| Period | Revenue ₹cr | Net profit ₹cr | EPS ₹ | OPM | NPM |
|---|---|---|---|---|---|
| Jun-26 · Q | 206.97 | 21.13 | 2.26 | 21.08% | 10.21% |
| Mar-26 · Q | 237.95 | 20.92 | 2.29 | 17.84% | 8.79% |
| FY25-26 | 886.87 | 87.61 | 9.58 | 20.21% | 9.88% |
Quarter on quarter
- Revenue, quarter on quarter
- -13.0%
- Net profit, quarter on quarter
- +1.0%
- Operating margin, quarter on quarter
- +324 bps
Disclosure profile 23 filings in the window
| Tag | Filings |
|---|---|
| Selected | |
| Board Outcome | 1 |
| Change in Management | 1 |
| Credit Rating | 1 |
| Results | 1 |
| Selected sub-total | 4 |
| Procedural | |
| General | 5 |
| AGM / EGM | 4 |
| Newspaper Publication | 2 |
| Record Date | 2 |
| Analyst / Investor Meet | 1 |
| Annual Report | 1 |
| BRSR | 1 |
| Board Meeting | 1 |
| Compliance Certificate | 1 |
| Trading Window | 1 |
| Procedural sub-total | 19 |
| Total | 23 |
Disclosure regime
LODR Reg 30
Read with Schedule III Part A. An equity filer in BSE Group B, so the Regulation 30 disclosure framework and the Schedule III event list both apply.
Filing rhythm · 93 trading days
23 filings · 4 selected · busiest 2026-07-31
Filing rhythm · the twelve most recent
2026-08-272026-10-07
SelectedProcedural
Filings
23 in the window · 5 earlier on record
-
7 October 2026 ·
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Reg 74(5) of SEBI DP Regulations for quarter ended 30 September 2026
Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →
-
30 September 2026 ·
Shareholder Meeting / Postal Ballot-Scrutinizer's Report
Scrutinizer report
AGM/EGM / AGM View filing →
-
29 September 2026 ·
Shareholder Meeting / Postal Ballot-Outcome of AGM
Proceedings of the Annual General Meeting of the Company
AGM/EGM / AGM View filing →
-
24 September 2026 ·
Closure of Trading Window
Trading window closure for the quarter and half year ended on 30 September 2026
Insider Trading / SAST / Closure of Trading Window View filing →
-
10 September 2026 ·
Analyst / Investor Meet - Intimation
Investors Group Meeting
Company Update / Analyst / Investor Meet View filing →
-
4 September 2026 ·
Letter To Shareholders Regarding Annual Report
Letter to Shareholders
Company Update / General View filing →
-
4 September 2026 ·
Business Responsibility and Sustainability Reporting (BRSR)
BRSR for the Financial Year 2025-26
Others / Business Responsibility and Sustainability Reporting (BRSR) View filing →
-
4 September 2026 ·
Notice Of 38Th Annual General Meeting To Be Held On 29Th September, 2026
Notice of 38th Annual General Meeting for the FY 2025-26
AGM/EGM / AGM View filing →
-
4 September 2026 ·
Reg. 34 (1) Annual Report.
Annual Report for the Financial Year 2025-26
Others / Reg. 34 (1) Annual Report View filing →
-
2 September 2026 ·
-
27 August 2026 ·
Change In Record Date
Record date for Dividend has been changed from 16th September, 2026 to 22nd September, 2026.
Corp. Action / Record Date View filing →
-
27 August 2026 ·
Intimation For Change In The Date Of 38Th Annual General Meeting, Book Closure And Record Date Of The Company
Change in the date of 38th AGM of the Company from 23rd September, 2026 to 29th September, 2026.
AGM/EGM / AGM View filing →
-
21 August 2026 ·
Newspaper Publication
Copy of newspaper publication regarding the 38th Annual General Meeting to be held through VC/ other Audio Visual Means
Company Update / Newspaper Publication View filing →
-
6 August 2026 ·
Intimation On Tax Deduction At Source On Dividend
Please find the enclosure
Company Update / General View filing →
-
31 July 2026 ·
-
31 July 2026 ·
-
31 July 2026 ·
-
31 July 2026 ·
Financial Results For The Quarter Ended 30Th June, 2026
Please find the enclosure
Result / Financial Results View filing →
-
31 July 2026 ·
Board Meeting Outcome for Outcome Of Board Meeting And Financial Results
Please find the enclosure
Board Meeting / Outcome of Board Meeting View filing →
-
29 July 2026 ·
Update on board meeting
The Board Meeting to be held on 01/08/2026 has been revised to 31/07/2026 The Board Meeting to be held on 01/08/2026 has been revised to 31/07/2026
Company Update / Board Meeting Rescheduled View filing →
-
22 July 2026 ·
Newspaper Publication
Copy of Newspaper Publication for information regarding transfer of shares to IEPF.
Company Update / Newspaper Publication View filing →
-
22 July 2026 ·
Reminder Letter For Transfer Of Shares To Investor Education And Protection Fund (IEPF)
Please find attached
Company Update / General View filing →
-
20 July 2026 ·
Disclosure Under Regulation 30 Of The SEBI (LODR) Regulations, 2015.
Please find the annexure.
Company Update / General View filing →
RSS feed for SMS Pharmaceuticals Ltd · the 50 most recent filings